Abstracts

THE RV144 VACCINE PRIMED IgG4 AND V1V2-ADCP RESPONSES IN HIV BREAKTHROUGH INFECTIONS

The RV144 vaccine efficacy trial showed a reduction in HIV infections that associated with stronger binding antibody (Ab) responses against Env variable loops V1V2. High levels of Ab-dependent cellular cytotoxicity (ADCC) together with low plasma levels of Env-specific IgA also correlated with decreased infection risk. Exact mechanisms of prevention remain unclear. To better understand the effect…

METHOTREXATE BLOCKS PROLIFERATION NOT INFLAMMATION TO MODULATE IMMUNITY

Inflammation associated with increased risk of comorbidities persists in people living with HIV (PLWH) on combination antiretroviral therapy (ART). Low-dose methotrexate (MTX) is an anti-inflammatory treatment for rheumatological disorders. A recent placebo-controlled trial (ACTG A5314) of low-dose MTX in PLWH found no changes in plasma inflammatory indices, but numbers of total and cycling (Ki-67+) CD4…

ENHANCED COMPLEMENT ACTIVITY DOES NOT IMPROVE PROTECTION IN SHIV-CHALLENGED MACAQUES

Fc modified bNAbs are being developed for prophylactic and therapeutic treatment of HIV. Extended half-life and reduced immunogenicity modifications have proven effective, but attempts to improve bNAb efficacy by enhancing affinity for Fcg Receptors alone have not worked in SHIV-challenged macaques. In this model, ablating FcgR binding reduced protection, but the role of complement appeared limited. We hypothesized…

PHASE I/II RANDOMIZED STUDY: THERAPEUTIC DENDRITIC CELL VACCINE PLUS PEGYLATED INF-Α

A double-blind placebo-controlled randomized therapeutic vaccine trial with myeloid derived-dendritic cells (MD-DC) loaded with heat-inactivated autologous HIV-1 (HIAH)  plus pegylated Interferon-alpha (pIFN) in HIV-1 chronic infected patients on antiretroviral treatment (ART) to achieve functional cure was performed. 36 patients on successful ART with CD4+ ≥450 cells/mm3 were randomized 1:1:1:1 and 29 received at w0, 2…

INTERFERON-Α MODULATES THE HOST GLYCOSYLATION MACHINERY DURING TREATED HIV INFECTION

A comprehensive understanding of host factors modulated by the key antiviral cytokine interferon-α (IFNα) is imperative for harnessing its beneficial effects while avoiding its detrimental side-effects, during chronic diseases such as HIV infection. Cytokines modulate host glycosylation, and the host glycome (circulating glycans and cell-surface glycans) plays a critical role in mediating several cellular processes…

BUTYROPHILINS: NOVEL IMMUNE CHECKPOINT TARGETS FOR HIV

Overexpression of immune-checkpoint receptors (IRs) has been associated with T-cell exhaustion and overall dysfunction in HIV. CD4 T-cells expressing IRs (e.g, PD-1, CTLA-4, LAG-3) enrich for integrated provirus and likely contribute to viral persistence during ART suppression. We identified a class of IRs, buytrophilins (BTNs), with high homology to B7 family members (e.g., PD-L1 and…